Overview

Vivitrol Treatment for Cannabis Use Disorder

Status:
Not yet recruiting
Trial end date:
2021-02-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to investigate the safety and effectiveness of 12 weeks treatment with an extended-release injectable form of naltrexone (Vivitrol) combined with a psychological intervention in 10 treatment-seeking adults with Cannabis Use Disorder. The hypotheses are that Vivitrol combined with a psychological intervention will be well tolerated, and will reduce cannabis use, improve abstinence rates, and reduce cannabis withdrawal and craving.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre for Addiction and Mental Health
Treatments:
Naltrexone
Criteria
Inclusion Criteria:

- Adult (18-64) male or female (gender to be analyzed as a covariate)

- Understand and willing to comply with study requirements and restrictions

- Willing to use appropriate contraceptive method throughout the study

- Otherwise healthy as judged by investigator based on medical history, physical exam,
vitals, ECG and labs

- DSM 5 criteria for current CUD

- Report cannabis as primary drug of abuse

- Have cannabis positive urine drug screen

- Treatment seeking cannabis smoker

Exclusion Criteria:

- Meets DSM 5 criteria for a current axis I disorder including substance use disorder
other than cannabis, nicotine or caffeine dependence.

- Unstable medical conditions

- Pregnant or breast-feeding

- Positive urine drug test for opioids (including methadone, morphine, buprenorphine) or
benzodiazepines (unless prescribed) at baseline

- Any IM gluteal administration 30 days prior to baseline

- Participation in a clinical trial of a pharmacological agent within 30 days prior to
baseline

- Known intolerance and/or hypersensitivity to naltrexone, carboxymethylcellulose, or
polylactide-coglycolide

- Any finding that, in the view of the principal investigator, would compromise the
subject's ability to fulfill the protocol visit schedule or visit requirement (e.g.
unadjudicated charges and/or pending parole hearings)